C4 Therapeutics (CCCC) vs Kyverna Therapeutics (KYTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
C4 Therapeutics (CCCC) has outperformed Kyverna Therapeutics (KYTX) over the past year, gaining 24.8% versus a gain of 14.0%. Kyverna Therapeutics is the larger company by market cap ($381.6 million vs $346.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CCCC | KYTX |
|---|---|---|
| Share price | $2.82 | $6.17 |
| Market cap | $346.93M | $381.57M |
| 1-day change | -2.08% | +0.16% |
| YTD return | +47.64% | -34.36% |
| 1-year return | +24.78% | +14.05% |
| 5-year return | -93.57% | — |
| EPS (TTM) | $-0.91 | $-2.93 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.17 | $13.67 |
| 52-week low | $1.69 | $5.94 |
| Distance from 52-week high | -45.45% | -54.86% |
| Average volume | 2.39M | 907.11K |
| Shares outstanding | 123.03M | 61.84M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CCCC has outperformed KYTX by 10.7 percentage points over the past year.
CCCC vs KYTX FAQ
Which is bigger, C4 Therapeutics or Kyverna Therapeutics?
Kyverna Therapeutics (KYTX) is larger, with a market capitalization of $381.57M compared with $346.93M for C4 Therapeutics (CCCC).
Which stock has performed better over the past year, CCCC or KYTX?
CCCC returned +24.78% over the past 12 months, compared with +14.05% for KYTX (price return, excluding dividends). Past performance does not predict future results.
Are C4 Therapeutics and Kyverna Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.